These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 17563271

  • 1. Etanercept: long-term clinical experience in rheumatoid arthritis and other arthritis.
    Cobo-Ibáñez T, Martín-Mola E.
    Expert Opin Pharmacother; 2007 Jun; 8(9):1373-97. PubMed ID: 17563271
    [Abstract] [Full Text] [Related]

  • 2. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR, Keating GM.
    Drugs; 2002 Jun; 62(17):2493-537. PubMed ID: 12421111
    [Abstract] [Full Text] [Related]

  • 3. Spotlight on etanercept in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR, Keating GM.
    BioDrugs; 2003 Jun; 17(2):139-45. PubMed ID: 12641492
    [Abstract] [Full Text] [Related]

  • 4. Etanercept: a review of its use in the management of rheumatoid arthritis.
    Dhillon S, Lyseng-Williamson KA, Scott LJ.
    Drugs; 2007 Jun; 67(8):1211-41. PubMed ID: 17521223
    [Abstract] [Full Text] [Related]

  • 5. The soluble tumor necrosis factor receptor etanercept: a new strategy for the treatment of autoimmune rheumatic disease.
    Cole P, Rabasseda X.
    Drugs Today (Barc); 2004 Apr; 40(4):281-324. PubMed ID: 15190385
    [Abstract] [Full Text] [Related]

  • 6. Etanercept in arthritis.
    Scott DL.
    Int J Clin Pract; 2005 Jan; 59(1):114-8. PubMed ID: 15707475
    [Abstract] [Full Text] [Related]

  • 7. Etanercept: therapeutic use in patients with rheumatoid arthritis.
    Garrison L, McDonnell ND.
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I65-9. PubMed ID: 10577976
    [Abstract] [Full Text] [Related]

  • 8. Treatment of rheumatoid arthritis with etanercept.
    Genovese MC, Kremer JM.
    Rheum Dis Clin North Am; 2004 May; 30(2):311-28, vi-vii. PubMed ID: 15172043
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.
    Fleischmann R, Iqbal I, Nandeshwar P, Quiceno A.
    Drug Saf; 2002 May; 25(3):173-97. PubMed ID: 11945114
    [Abstract] [Full Text] [Related]

  • 10. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
    Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ.
    N Engl J Med; 1999 Jan 28; 340(4):253-9. PubMed ID: 9920948
    [Abstract] [Full Text] [Related]

  • 11. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
    Smolen JS, Nash P, Durez P, Hall S, Ilivanova E, Irazoque-Palazuelos F, Miranda P, Park MC, Pavelka K, Pedersen R, Szumski A, Hammond C, Koenig AS, Vlahos B.
    Lancet; 2013 Mar 16; 381(9870):918-29. PubMed ID: 23332236
    [Abstract] [Full Text] [Related]

  • 12. Etanercept (Enbrel) -- an update.
    Goffe B.
    Skin Therapy Lett; 2013 Mar 16; 9(10):1-4, 9. PubMed ID: 15657632
    [Abstract] [Full Text] [Related]

  • 13. Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of etanercept.
    van Luijn JC, Danz M, Bijlsma JW, Gribnau FW, Leufkens HG.
    Scand J Rheumatol; 2011 May 16; 40(3):183-91. PubMed ID: 20858147
    [Abstract] [Full Text] [Related]

  • 14. Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein.
    Zhou H.
    J Clin Pharmacol; 2005 May 16; 45(5):490-7. PubMed ID: 15831771
    [Abstract] [Full Text] [Related]

  • 15. Clinical experience with soluble TNF p75 receptor in rheumatoid arthritis.
    Franklin CM.
    Semin Arthritis Rheum; 1999 Dec 16; 29(3):172-81. PubMed ID: 10622681
    [Abstract] [Full Text] [Related]

  • 16. COMET's path, and the new biologicals in rheumatoid arthritis.
    Kremer JM.
    Lancet; 2008 Aug 02; 372(9636):347-8. PubMed ID: 18635257
    [No Abstract] [Full Text] [Related]

  • 17. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F.
    Recenti Prog Med; 2003 Sep 02; 94(9):361-79. PubMed ID: 12942798
    [Abstract] [Full Text] [Related]

  • 18. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM, Kirby B.
    BioDrugs; 2005 Sep 02; 19(1):47-57. PubMed ID: 15691217
    [Abstract] [Full Text] [Related]

  • 19. Etanercept in the treatment of rheumatoid arthritis.
    Hunt L, Emery P.
    Expert Opin Biol Ther; 2013 Oct 02; 13(10):1441-50. PubMed ID: 23991717
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
    Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, Martín Mola E, Pavelka K, Sany J, Settas L, Wajdula J, Pedersen R, Fatenejad S, Sanda M, TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) study investigators.
    Lancet; 2004 Feb 28; 363(9410):675-81. PubMed ID: 15001324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.